tradingkey.logo
tradingkey.logo
Suchen

Solventum Corp

SOLV
Zur Watchlist hinzufügen
79.530USD
+1.610+2.07%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
13.77BMarktkapitalisierung
9.67KGV TTM

mehr Informationen über Solventum Corp Unternehmen

Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.

Solventum Corp Informationen

BörsenkürzelSOLV
Name des UnternehmensSolventum Corp
IPO-datumMar 26, 2024
CEOHanson (Bryan C)
Anzahl der mitarbeiter22000
WertpapierartOrdinary Share
GeschäftsjahresendeMar 26
AddresseC/O 3M Company
StadtST. PAUL
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl55144-1000
Telefon16517331110
Websitehttps://www.solventum.com/en-us/home/
BörsenkürzelSOLV
IPO-datumMar 26, 2024
CEOHanson (Bryan C)

Führungskräfte von Solventum Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Wayde D. McMillan
Mr. Wayde D. McMillan
Chief Financial Officer
Chief Financial Officer
48.64K
+10.48%
Ms. Amy Landucci
Ms. Amy Landucci
Chief Information and Digital Officer
Chief Information and Digital Officer
39.89K
+6.03%
Mr. Paul S. Harrington
Mr. Paul S. Harrington
Chief Supply Chain Officer
Chief Supply Chain Officer
20.45K
+11.16%
Ms. Tammy L. Gomez
Ms. Tammy L. Gomez
Chief Human Resources Officer
Chief Human Resources Officer
13.36K
+17.15%
Mr. Chris Barry
Mr. Chris Barry
Executive Vice President and Group President, Medical Surgical
Executive Vice President and Group President, Medical Surgical
9.21K
+49.77%
Mr. Carlos Alban
Mr. Carlos Alban
Independent Director
Independent Director
8.95K
+38.04%
Mr. Glenn A. Eisenberg
Mr. Glenn A. Eisenberg
Independent Director
Independent Director
8.95K
+38.04%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
8.95K
+38.04%
Mr. John H. Weiland
Mr. John H. Weiland
Independent Director
Independent Director
8.95K
+38.04%
Mr. Darryl L. Wilson
Mr. Darryl L. Wilson
Independent Director
Independent Director
8.95K
+38.04%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Wayde D. McMillan
Mr. Wayde D. McMillan
Chief Financial Officer
Chief Financial Officer
48.64K
+10.48%
Ms. Amy Landucci
Ms. Amy Landucci
Chief Information and Digital Officer
Chief Information and Digital Officer
39.89K
+6.03%
Mr. Paul S. Harrington
Mr. Paul S. Harrington
Chief Supply Chain Officer
Chief Supply Chain Officer
20.45K
+11.16%
Ms. Tammy L. Gomez
Ms. Tammy L. Gomez
Chief Human Resources Officer
Chief Human Resources Officer
13.36K
+17.15%
Mr. Chris Barry
Mr. Chris Barry
Executive Vice President and Group President, Medical Surgical
Executive Vice President and Group President, Medical Surgical
9.21K
+49.77%
Mr. Carlos Alban
Mr. Carlos Alban
Independent Director
Independent Director
8.95K
+38.04%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Solventum Corp?

Die fünf größten Anteilseigner von Solventum Corp sind: Mr. Wayde D. McMillan

Wie viele Institutionen halten Anteile an Solventum Corp (SOLV)?

Mit Stand vom 2026Q1 halten 1825 Institutionen Anteile an Solventum Corp, mit einem Gesamtmarktwert von etwa 129.24M, was 74.63% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -6936666.00 gestiegen.
KeyAI